Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pakkanen, Sari
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines	Recruiting	4	60	Europe	Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral®	Helsinki University Central Hospital, University of Helsinki	Vaccine-Preventable Diseases, Typhoid Fever, Cholera	12/25	12/25
FMT-UTI, NCT06050148: Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections	Recruiting	2/3	100	Europe	Feacal microbial transplantation (FMT), Placebo transplantation (PT)	Helsinki University Central Hospital, University of Helsinki	Recurrent Urinary Tract Infection	12/28	12/29
Häkkinen, Hanni
FMT-UTI, NCT06050148: Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections	Recruiting	2/3	100	Europe	Feacal microbial transplantation (FMT), Placebo transplantation (PT)	Helsinki University Central Hospital, University of Helsinki	Recurrent Urinary Tract Infection	12/28	12/29